Volume : 13, Issue : 04, April – 2026
Title:
BRIDGING THE KNOWLEDGE GAP: ROLE OF PHARMACIST EDUCATION IN IMPROVING KAP AND QUALITY OF LIFE IN ALLERGIC RHINITIS
Authors :
Sai Pawan R Adepu, Kumbagalla Harshitha, Maria Anam, Kubra Aaisha Imaama, Imamuddin Ansari
Abstract :
Background: Allergic rhinitis is a chronic inflammatory condition of the nasal mucosa caused by IgE-mediated hypersensitivity To allergens such as pollen dust mites and molds. It presents with symptoms like sneezing, nasal congestion, rhinorrhea and itching. The condition significantly affects quality of life sleep and daily activities. Its prevalence is increasing due to urbanization pollution and lifestyle changes making effective patient education and management essential.
Methodology: A Prospective observational study was conducted over 6 months among 650 allergic rhinitis patients. Subjects were randomized into test and control groups using block randomization. Data were collected using KAP & RQLQ questionnaire at baseline and follow ups. The test group received education at each visit while control group received only at final follow up.
Results: The test group showed significant improvement in KAP scores compared to the control group (p<005). RQLQ Scores decreased significantly in test group indicating improved quality of life. No major improvement was observed in the control group.
Conclusion: Pharmacist intervention on knowledge adherence and quality of life in allergy clinics patients had a significant impact.
Keywords: Allergic rhinitis, IgE, KAP, RQLQ, Pharmacist counselling
Cite This Article:
Please cite this article in press Sai Pawan R Adepu et a bridging the knowledge gap: Role of pharmacist education in improving KAP and quality of life in allergic rhinitis, Indo Am. J. P. Sci, 2026; 13(04).
REFERENCES:
1. Chew CC, Lim XJ, Letchumanan P, Chong CP, George D, Rajan P, et al. The effectiveness of pharmacist-led educational model in adult patients with allergic rhinitis: a single-center randomized control trial protocol (AR-PRISE RCT). Trials. 2024;25(1):279-288.
2. Todorova A, Tsvetkova A, Mihaylova S, Andreevska K, Kondova A, Arnaoudova M, et al. The impact of pharmaceutical care on improving the quality of life in patients with allergic rhinitis. CBU Int Conf Proc. 2017;5(1):1022-1027.
3. Al-Taie Anmar.A Systemic review for Improper application of nasal spray in allergic rhinitis: the role of community pharmacist for patient education and counseling. Int J Pharm Pract. 2018;26(3):221-229.
4. Ali SM, Ishaq W, Shabbir R, Imran R. Insights on allergic rhinitis management and impact of pharmacist-led educational intervention on patient’s knowledge. Pharmacol Drug Res. 2024;1(1):1-22.
5. O Lourenço, S Bosnic-Anticevich, Costa E, et al. Managing allergic rhinitis in the pharmacy: an ARIA guide for implementation in practice. Allergy. 2019;74(7):1216-1230.
6. Compalati E, Bousquet J, Mullol J, et al. The international survey on the management of allergic rhinitis. Allergy. 2010;65(12):1523-1530.
7. Chew CC, Lim XJ, Letchumanan P, Rajan P, Chong CP, George D, et al. Pharmacist-led approach improves allergic rhinitis outcomes. JAMA Netw Open. 2025;8(7):e2517160.
8. Deka B, Bhattacharjee B, Ahmed A, et al. Clinical management of allergic rhinitis: a comprehensive review. Cureus. 2023;15(2):e35000.
9. Bhargava C, Verma M, Jakes RW, et al. Knowledge and attitude among patients and physicians on allergic rhinitis (KAPPA): an international survey. Allergy. 2007;62(1):85-90.
10. Bernstein JA, Bernstein JS, Makol R, Ward S, et al. Allergic rhinitis: a review. J Allergy Clin Immunol. 2017;140(4):950-958.
11. Siddiqui ZA, Walker A, Pirwani MM, Tahiri M, Syed I, et al. Allergic rhinitis: diagnosis and management. Br J Hosp Med. 2020;81(3):1-7.
12. Tameeris E, Bohnen AM, Bindels PJE, et al. The effect of allergic rhinitis treatment on asthma control: a systematic review. NPJ Prim Care Respir Med. 2019;29(1):1-8.
13. Singh AK, Shaili S, Siddiqui A, et al. Unravelling allergic rhinitis: exploring pathophysiology, advances in treatment, and future directions. Cureus. 2022;14(8):e27954.
14. Sharma K, Akre S, Chakole S, Wanjari MB, et al. Allergic rhinitis and treatment modalities: a review of literature. J Pharm Res Int. 2021;33(37):53-60.
15. Rosenfield L, Keith PK, Quirt J, Small P, Ellis AK, et al. Allergic rhinitis. Allergy Asthma Clin Immunol. 2011;7(Suppl 1):S3.
16. Naclerio RM, Bousquet J, et al. Current management of allergic rhinitis. J Allergy Clin Immunol. 2020;145(4):1089-1096.
17. Prasad V, Abdullah M, Nordin F, et al. Prevalence, causes and treatments of allergic rhinitis in Malaysia: a literature review. Asian Pac J Allergy Immunol. 2018;36(4):189-197.
18. Hossenbaccus L, Linton S, Garvey S, Ellis AK, et al. Towards definitive management of allergic rhinitis. Allergy Asthma Clin Immunol. 2020;16(1):1-9.
19. Mishra V, Hari BR, et al. Epidemiology, prevention, and clinical management of allergic rhinitis. J Fam Med Prim Care. 2020;9(2):575-580.
20. Greiner AN, Hellings PW, Rotiroti G, et al. Allergic rhinitis. Lancet. 2011;378(9809):2112-2122.
21. Wheatley LM, Togias A. Allergic rhinitis. N Engl J Med. 2015;372(5):456-463.
22. Bousquet J, Anto JM, Bachert C, Baiardini I, et al. Allergic rhinitis. Nat Rev Dis Primers. 2020;6:95.
23. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma (ARIA). J Allergy Clin Immunol. 2001;108(5 Suppl):S147-S334.
24. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update. Allergy. 2008;63(Suppl 86):8-160.
25. Peter Small, paul.keith, harold kim, et.al “Allergy, Asthma and clinical Immunology”, 2018 September 12. 14(15).
26. Peter Small, Harold Kim, et.al.”Allergy, Asthma and clinical Immunology”. 2011 November 10.7(S3)
27. Pawankar R, Mori S, Ozu C, Kimura S, et al. Overview on the pathomechanisms of allergic rhinitis. Asia Pac Allergy. 2011;1(3):157-167.
28. Meng Y, Wang C, Zhang L, et al. Recent developments and highlights in allergic rhinitis. Allergy. 2019;74(12):2320-2331.
29. Rondón C, Campo P, Togias A, et al. Local allergic rhinitis: concept, pathophysiology, and management. J Allergy Clin Immunol. 2012;129(6):1460-1467.
30. José J, Cvetkovski B, Kritikos V, et al. Interventions delivered in the community pharmacy to manage allergic rhinitis. Int J Clin Pharm. 2020;42(4):998-1008.
31. Todorova A, Tsvetkova A, Mihaylova S, et.al.”The impact of pharmaceutical care on improving the quality of life in patients with allergic rhinitis”. CBU International Conference Proceedings. 2017 Sep 24;5(0):1022–1027.
32. Yap JSY, Tang CWQ, Hor HML, et al. Process evaluation of the community pharmacist-led allergic rhinitis management. Res Social Adm Pharm. 2021;17(10):1838-1845.
33. Tan R. The management of allergic rhinitis in the community pharmacy: a real-life study of current practice in Australia. Int J Pharm Pract. 2019;27(3):241-248.
34. May JR, Dolen WK, et al. Management of allergic rhinitis: a review for the community pharmacist. Clin Ther. 2017;39(12):2410-2419.
35. Bousquet J, Van Cauwenberge P, Khaltaev N, et al. ARIA in the pharmacy: management of allergic rhinitis symptoms in the pharmacy—Allergic rhinitis and its impact on asthma. Allergy. 2004 Apr;59(4):373-387. doi:10.1111/j.1398-9995.2003.00468.x. Available from:https://pubmed.ncbi.nlm.nih.gov/15005760/
36. Paoletti G, Giua C, Marti A, et al. ARIA-Italy managing allergic rhinitis and asthma in a changing world: the role of the pharmacist. World Allergy Organ J. 2025;18(5):101055.
37. Arsoy G, Varış A, Saloumi LM, Abdi A, Başgut B. Insights on allergic rhinitis management from a Northern Cyprus perspective and evaluation of the impact of pharmacist-led educational intervention on patients’ outcomes. Medicina. 2018;54(4):63.
38. Varshney J, Varshney H. Allergic rhinitis: an overview. Indian J Otolaryngol Head Neck Surg. 2015;67(2):143-149.
39. Russell JR, May JR, Dolen WK. Management of allergic rhinitis for pharmacists. Ann Allergy Asthma Immunol. 2018;120(2):127-134.
40. Pawankar R. Allergic rhinitis and asthma: evidence for ARIA guidelines. World Allergy Organ J. 2012;5(Suppl 3):S212-S216.